Stryker Unveils Synchfix EVT for Flexible Syndesmotic Ankle Fixation

Why It Matters

By offering a streamlined, knotless solution for syndesmotic injuries, Synchfix EVT can shorten surgery times and expand treatment options for younger patients, potentially boosting surgeon adoption and market share in orthopaedic devices.

Key Takeaways

• First flexible syndesmotic device for adolescents
• Integrated suture tensioning reduces procedural steps
• Low-profile titanium implant improves patient comfort
• Single-use, knotless system enhances sterility
• Supports Weber B, C, Maisonneuve fracture fixation

Pulse Analysis

Syndesmotic ankle injuries, often sustained in high‑impact sports or complex fractures, demand precise stabilization to prevent chronic instability. Traditional screw or rigid suture‑button constructs can be technically demanding and may require later removal, limiting their appeal. The market has therefore been primed for a more adaptable solution that maintains fixation strength while accommodating natural ankle motion, especially in younger, active patients.

Synchfix EVT addresses these gaps with an integrated, single‑handed tensioning handle and a low‑profile titanium button that flexes with the syndesmosis. Its knotless, sterile, single‑use design eliminates intra‑operative knot tying, reducing operative time and infection risk. Notably, the device is the first flexible syndesmotic system cleared for adolescent use, expanding the therapeutic arsenal for pediatric orthopaedic surgeons and aligning with the growing demand for age‑appropriate implants. Early clinical feedback suggests improved postoperative comfort and quicker return to activity, key metrics for both patients and providers.

From a business standpoint, Stryker’s introduction of Synchfix EVT complements its broader foot‑and‑ankle portfolio and leverages the momentum from its 11.2% revenue increase in the vascular segment. By differentiating with a flexible, adolescent‑friendly product, Stryker positions itself ahead of competitors still reliant on rigid fixation technologies. The device’s launch at the American College of Foot and Ankle Surgeons conference underscores a strategic push to capture market share in a niche yet expanding segment, potentially driving incremental sales and reinforcing Stryker’s reputation for innovative orthopaedic solutions.